NO20070176L - Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav - Google Patents

Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav

Info

Publication number: NO20070176L
Authority: NO; Norway
Prior art keywords: pyrazoles; compounds; drugs containing; glycoside derivatives; new fluorine
Prior art date: 2004-06-11

Application number

NO20070176A

Other languages

English (en)

Norwegian (no)

Inventor

Heiner Glombik

Hubert Heuer

Martin Bickel

Wendelin Frick

Harm Brummerhop

Oliver Plettenburg

Stefan Theis

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-11

Filing date

2007-01-10

Publication date

2007-03-09

2007-01-10 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2007-03-09 Publication of NO20070176L publication Critical patent/NO20070176L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Genetics & Genomics (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
AIDS & HIV (AREA)

NO20070176A 2004-06-11 2007-01-10 Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav NO20070176L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004028241A DE102004028241B4 (de)	2004-06-11	2004-06-11	Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
PCT/EP2005/005959 WO2005121161A1 (de)	2004-06-11	2005-06-03	Neue fluorglykosidderivate von pyrazolen, diese verbindungen enthaltende arzneimittel und deren verwendung

Publications (1)

Publication Number	Publication Date
NO20070176L true NO20070176L (no)	2007-03-09

Family

ID=35355753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20070176A NO20070176L (no)	2004-06-11	2007-01-10	Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav

Country Status (33)

Country	Link
US (1)	US7820804B2 (sr)
EP (1)	EP1758914B1 (sr)
JP (1)	JP4996464B2 (sr)
CN (1)	CN100582116C (sr)
AR (1)	AR049393A1 (sr)
AU (1)	AU2005252329B2 (sr)
BR (1)	BRPI0510770A (sr)
CA (1)	CA2570042C (sr)
CR (1)	CR8773A (sr)
CY (1)	CY1107426T1 (sr)
DE (2)	DE102004028241B4 (sr)
DK (1)	DK1758914T3 (sr)
EC (1)	ECSP067054A (sr)
ES (1)	ES2296180T3 (sr)
HR (1)	HRP20080023T3 (sr)
IL (1)	IL179757A (sr)
MA (1)	MA28653B1 (sr)
MX (1)	MXPA06013513A (sr)
MY (1)	MY143565A (sr)
NO (1)	NO20070176L (sr)
NZ (1)	NZ551948A (sr)
PE (1)	PE20060297A1 (sr)
PL (1)	PL1758914T3 (sr)
PT (1)	PT1758914E (sr)
RS (1)	RS50541B (sr)
RU (1)	RU2370499C2 (sr)
SI (1)	SI1758914T1 (sr)
TN (1)	TNSN06409A1 (sr)
TW (1)	TWI382030B (sr)
UA (1)	UA89787C2 (sr)
UY (1)	UY28955A1 (sr)
WO (1)	WO2005121161A1 (sr)
ZA (1)	ZA200608832B (sr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200637869A (en)	2005-01-28	2006-11-01	Chugai Pharmaceutical Co Ltd	The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
DE102005026762A1 (de)	2005-06-09	2006-12-21	Sanofi-Aventis Deutschland Gmbh	Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
PE20110235A1 (es)	2006-05-04	2011-04-14	Boehringer Ingelheim Int	Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
AR061026A1 (es)	2006-05-19	2008-07-30	Taisho Pharmaceutical Co Ltd	Compuesto glicitol c-fenilo y preparacion farmaceutica
CA2655937A1 (en)	2006-06-29	2008-01-03	Taisho Pharmaceutical Co., Ltd.	C-phenyl 1-thioglucitol compound
AU2007283113A1 (en)	2006-08-08	2008-02-14	Sanofi-Aventis	Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
DE102006053637B4 (de) *	2006-11-14	2011-06-30	Sanofi-Aventis Deutschland GmbH, 65929	Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
AU2007332476A1 (en)	2006-12-14	2008-06-19	Taisho Pharmaceutical Co., Ltd.	1-phenyl 1-thio-D-glucitol derivative
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP5272395B2 (ja) *	2007-12-12	2013-08-28	セントラル硝子株式会社	４−デオキシ−４−フルオロ−ｄ−グルコース誘導体の製造方法
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
AP2728A (en) *	2008-08-28	2013-08-31	Pfizer	Dioxa-bicyclo[3.2.1.] octane-2,3,4-triol derivatives
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
MY155658A (en)	2009-02-23	2015-11-13	Taisho Pharmaceutical Co Ltd	A-isopropylphenyl glucitol compounds as sglti inhibitors
EP2298782A1 (en)	2009-08-26	2011-03-23	Sanofi-Aventis	Method for producing pyrazole glycoside derivatives
KR20120060207A (ko) *	2009-08-26	2012-06-11	사노피	신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
WO2011039338A2 (en)	2009-10-02	2011-04-07	Sanofi-Aventis	Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
US8163704B2 (en)	2009-10-20	2012-04-24	Novartis Ag	Glycoside derivatives and uses thereof
DK2496583T3 (en)	2009-11-02	2015-02-02	Pfizer	Dioxa-bicyclo [3.2.1] octane-2,3,4-triol DERIVATIVES
US20120294936A1 (en)	2009-11-13	2012-11-22	Astrazeneca Uk Limited	Reduced mass metformin formulations
CN102740839B (zh)	2009-11-13	2015-05-06	阿斯利康(瑞典)有限公司	立即释放片剂
CN105193761B (zh)	2009-11-13	2019-12-06	阿斯利康(瑞典)有限公司	双层片剂
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
CA2807755A1 (en)	2010-08-20	2012-02-23	Taisho Pharmaceutical Co., Ltd.	Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof
ES2546253T3 (es)	2010-08-20	2015-09-22	Taisho Pharmaceutical Co., Ltd.	Compuesto 4-isopropil-6-metoxifenilglucitol
MX2013002146A (es)	2010-09-03	2013-04-03	Astrazeneca Uk Ltd	Formulaciones farmaceuticas que utilizan antioxidantes solubles en agua.
RU2607480C2 (ru)	2011-02-01	2017-01-10	Бристол-Майерс Сквибб Компани	Фармацевтические композиции, содержащие аминосоединение
EP2683703B1 (de)	2011-03-08	2015-05-27	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2766349B1 (de)	2011-03-08	2016-06-01	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683702B1 (de)	2011-03-08	2014-12-24	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en)	2011-03-08	2014-04-29	Sanofi	Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683704B1 (de)	2011-03-08	2014-12-17	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
US8614195B2 (en) *	2011-04-14	2013-12-24	Novartis Ag	Glycoside derivatives and uses thereof
AR087701A1 (es) *	2011-08-31	2014-04-09	Japan Tobacco Inc	Derivados de pirazol con actividad inhibidora de sglt1
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en)	2011-09-27	2013-04-04	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
UA113086C2 (xx)	2012-05-10	2016-12-12		Піразольні сполуки як інгібітори sglt1
TW201425326A (zh)	2012-10-05	2014-07-01	Lilly Co Eli	新穎脲化合物
MX346453B (es)	2013-02-04	2017-03-17	Taisho Pharmaceutical Co Ltd	Medicamento profilactico o terapeutico para el estreñimiento.
EP2774619B1 (de)	2013-03-04	2016-05-18	BioActive Food GmbH	Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen
AR098670A1 (es) *	2013-11-08	2016-06-08	Lilly Co Eli	Inhibidor de sglt1
EP2944311A1 (de)	2014-05-16	2015-11-18	BioActive Food GmbH	Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen
MX2020010433A (es) *	2018-04-04	2020-10-28	Japan Tobacco Inc	Compuestos de pirazol sustituidos con heteroarilo y uso farmaceutico de los mismos.
WO2020033919A1 (en)	2018-08-10	2020-02-13	Diapin Therapeutics, Llc	Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2176600T3 (es) *	1996-12-26	2002-12-01	Tanabe Seiyaku Co	Derivado de la propiofenona y procedimientos para su preparacion.
BRPI0013667B8 (pt) *	1999-08-31	2021-05-25	Kissei Pharmaceutical	derivados de glucopiranosiloxipirazol, composições medicinais contendo os mesmos e seus intermediários na produção deles
PH12000002657B1 (en) *	1999-10-12	2006-02-21	Bristol Myers Squibb Co	C-aryl glucoside SGLT2 inhibitors
ES2337127T3 (es) *	2000-11-02	2010-04-21	Ajinomoto Co., Inc.	Nuevos derivados de pirazol y remedios contra la diabetes que los contienen.
WO2002064839A2 (en) *	2001-02-14	2002-08-22	Tularik Inc.	Methods for the diagnosis and treatment of tumors employing the hepsin gene
US20030087843A1 (en) *	2001-09-05	2003-05-08	Washburn William N.	O-pyrazole glucoside SGLT2 inhibitors and method of use
BRPI0313290B1 (pt) *	2002-08-08	2016-12-06	Kissei Pharmaceutical	derivados de pirazol, promedicamento, composição farmacêutica, agentes terapêuticos e uso medicinal
JP2004137245A (ja) *	2002-08-23	2004-05-13	Kissei Pharmaceut Co Ltd	ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
AU2003262262A1 (en) *	2002-08-27	2004-03-19	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
CA2500873C (en) *	2002-10-04	2012-01-17	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
EP1568380A4 (en) *	2002-12-04	2009-10-21	Kissei Pharmaceutical	PREVENTION OR TREATMENT OF DISEASES DUE TO HYPERGLYCEMIA
DE10258008B4 (de) *	2002-12-12	2006-02-02	Sanofi-Aventis Deutschland Gmbh	Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
US7576064B2 (en) *	2003-06-20	2009-08-18	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivative, drug composition containing the same and production intermediate therefor

2004
- 2004-06-11 DE DE102004028241A patent/DE102004028241B4/de not_active Expired - Fee Related
2005
- 2005-06-03 DK DK05746637T patent/DK1758914T3/da active
- 2005-06-03 HR HR20080023T patent/HRP20080023T3/xx unknown
- 2005-06-03 UA UAA200700259A patent/UA89787C2/ru unknown
- 2005-06-03 CN CN200580019067A patent/CN100582116C/zh not_active Expired - Fee Related
- 2005-06-03 RS RSP-2008/0017A patent/RS50541B/sr unknown
- 2005-06-03 CA CA2570042A patent/CA2570042C/en not_active Expired - Fee Related
- 2005-06-03 SI SI200530142T patent/SI1758914T1/sl unknown
- 2005-06-03 JP JP2007526254A patent/JP4996464B2/ja not_active Expired - Fee Related
- 2005-06-03 PT PT05746637T patent/PT1758914E/pt unknown
- 2005-06-03 PL PL05746637T patent/PL1758914T3/pl unknown
- 2005-06-03 DE DE502005002056T patent/DE502005002056D1/de not_active Expired - Lifetime
- 2005-06-03 EP EP05746637A patent/EP1758914B1/de not_active Expired - Lifetime
- 2005-06-03 NZ NZ551948A patent/NZ551948A/en not_active IP Right Cessation
- 2005-06-03 WO PCT/EP2005/005959 patent/WO2005121161A1/de not_active Ceased
- 2005-06-03 MX MXPA06013513A patent/MXPA06013513A/es active IP Right Grant
- 2005-06-03 ES ES05746637T patent/ES2296180T3/es not_active Expired - Lifetime
- 2005-06-03 BR BRPI0510770-9A patent/BRPI0510770A/pt not_active IP Right Cessation
- 2005-06-03 AU AU2005252329A patent/AU2005252329B2/en not_active Ceased
- 2005-06-03 RU RU2007101154/04A patent/RU2370499C2/ru not_active IP Right Cessation
- 2005-06-09 MY MYPI20052616A patent/MY143565A/en unknown
- 2005-06-09 TW TW094118973A patent/TWI382030B/zh not_active IP Right Cessation
- 2005-06-10 UY UY28955A patent/UY28955A1/es unknown
- 2005-06-10 PE PE2005000666A patent/PE20060297A1/es not_active Application Discontinuation
- 2005-06-13 AR ARP050102406A patent/AR049393A1/es not_active Application Discontinuation
2006
- 2006-10-24 ZA ZA200608832A patent/ZA200608832B/en unknown
- 2006-11-27 CR CR8773A patent/CR8773A/es not_active Application Discontinuation
- 2006-11-30 IL IL179757A patent/IL179757A/en not_active IP Right Cessation
- 2006-12-05 MA MA29515A patent/MA28653B1/fr unknown
- 2006-12-06 US US11/567,410 patent/US7820804B2/en not_active Expired - Fee Related
- 2006-12-08 TN TNP2006000409A patent/TNSN06409A1/en unknown
- 2006-12-08 EC EC2006007054A patent/ECSP067054A/es unknown
2007
- 2007-01-10 NO NO20070176A patent/NO20070176L/no not_active Application Discontinuation
2008
- 2008-02-04 CY CY20081100139T patent/CY1107426T1/el unknown

Also Published As

Publication number	Publication date
JP2008501745A (ja)	2008-01-24
PL1758914T3 (pl)	2008-04-30
CN1964984A (zh)	2007-05-16
IL179757A0 (en)	2007-05-15
AR049393A1 (es)	2006-07-26
DK1758914T3 (da)	2008-03-17
EP1758914B1 (de)	2007-11-21
UA89787C2 (ru)	2010-03-10
AU2005252329A1 (en)	2005-12-22
ES2296180T3 (es)	2008-04-16
SI1758914T1 (sl)	2008-04-30
RU2370499C2 (ru)	2009-10-20
US20070197623A1 (en)	2007-08-23
TW200610527A (en)	2006-04-01
MY143565A (en)	2011-05-31
CN100582116C (zh)	2010-01-20
RS50541B (sr)	2010-05-07
US7820804B2 (en)	2010-10-26
EP1758914A1 (de)	2007-03-07
CR8773A (es)	2008-02-28
AU2005252329B2 (en)	2011-02-10
CA2570042A1 (en)	2005-12-22
PE20060297A1 (es)	2006-05-25
UY28955A1 (es)	2006-01-31
HRP20080023T3 (en)	2008-06-30
TWI382030B (zh)	2013-01-11
DE502005002056D1 (de)	2008-01-03
MA28653B1 (fr)	2007-06-01
PT1758914E (pt)	2008-01-31
DE102004028241B4 (de)	2007-09-13
CY1107426T1 (el)	2012-12-19
ECSP067054A (es)	2007-01-26
IL179757A (en)	2010-12-30
WO2005121161A1 (de)	2005-12-22
NZ551948A (en)	2010-04-30
CA2570042C (en)	2013-01-15
BRPI0510770A (pt)	2007-11-20
HK1100411A1 (zh)	2007-09-21
JP4996464B2 (ja)	2012-08-08
ZA200608832B (en)	2008-05-28
DE102004028241A1 (de)	2006-01-05
MXPA06013513A (es)	2007-03-01
RU2007101154A (ru)	2008-07-20
TNSN06409A1 (en)	2008-02-22

Legal Events

Date	Code	Title	Description
2015-01-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20070176L (no)	2007-03-09	Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav
NO20091893L (no)	2009-07-09	Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20050649L (no)	2005-04-01	Nye tiofenylglykosidderivater, fremgangsmate for fremstilling derav, medikamenter omfattende disse forbindelser og anvendelse derav
NO20064201L (no)	2006-12-13	Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20082445L (no)	2008-09-03	Neuropeptid-2 reseptor-agonister
NO20085066L (no)	2009-02-06	4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20066055L (no)	2007-01-24	Pyridinderivater
NO20053201L (no)	2005-08-04	Nye heterocykliske fluorglukosidderivater, legemidler inneholdende disse forbindelser og deres anvendelse.
NO20064166L (no)	2006-10-25	Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter
NO20083863L (no)	2008-12-03	Pyrazoler som 11-beta-hsd-1
NO20085067L (no)	2009-02-06	4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085064L (no)	2009-02-06	4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20074872L (no)	2007-10-30	Pyrazoler
NO20051165L (no)	2005-03-04	Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20060001L (no)	2006-03-02	Nye P2X7-reseptorantagonister og deres anvendelse
NO20084129L (no)	2008-10-29	Pyridin(3,4-B)Pyrazinoner
NO20076460L (no)	2008-02-19	Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav
NO20074391L (no)	2007-12-11	CIS-2,4,5-triaryl-imidazoliner og deres anvendelse som anti-cancer medikamenter
WO2007090141A3 (en)	2007-11-15	Pyrrolo [2, 3, b] pyridine derivatives useful as raf kinase inhibitors
NO20055977L (no)	2006-02-16	Nye benzimidazolderivater
NO20092058L (no)	2009-09-17	Heteroaryl pyrrolidinyl ketonderivater
NO20072389L (no)	2007-08-23	Substituerte benzokinolizinderivater
NO20061839L (no)	2006-06-26	Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
NO20055766L (no)	2005-12-05	Positive modulatorer av nikotinacetylcholinreseptorer
NO20060147L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav